| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | NEUTRAL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.83▼ | 1.81▲ | 1.80▲ | 2.02▼ | 2.09▼ |
| MA10 | 1.82▲ | 1.80▲ | 1.77▲ | 2.25▼ | 2.14▼ |
| MA20 | 1.81▲ | 1.77▲ | 1.83▼ | 2.23▼ | 2.09▼ |
| MA50 | 1.80▲ | 1.99▼ | 2.23▼ | 2.13▼ | 2.50▼ |
| MA100 | 1.77▲ | 2.25▼ | 2.27▼ | 2.13▼ | 2.26▼ |
| MA200 | 1.82▲ | 2.28▼ | 2.22▼ | 2.40▼ | 3.22▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | 0.026▲ | 0.028▲ | -0.076▼ | 0.001▲ |
| RSI | 57.932▲ | 47.956▼ | 38.170▼ | 36.888▼ | 43.212▼ |
| STOCH | 79.167 | 76.554 | 65.902 | 35.566 | 53.261 |
| WILL %R | -25.000▲ | -16.949▲ | -16.949▲ | -78.166▼ | -75.847▼ |
| CCI | 81.967 | 97.336 | 119.432▲ | -160.581▼ | -110.879▼ |
|
Thursday, June 12, 2025 03:03 AM
The US Food and Drug Administration (FDA) yesterday approved Nuvation Bio’s (NYSE: NUVB) Ibtrozi (taletrectinib), a kinase inhibitor, for adults with locally advanced or metastatic ROS1-positive ...
|
|
Wednesday, June 11, 2025 11:43 AM
The U.S. Food and Drug Administration said on Wednesday it has approved Nuvation Bio's drug for patients with a rare and aggressive form of lung cancer.
|
|
Wednesday, June 11, 2025 11:41 AM
Short interest in Nuvation Bio Inc (NYSE:NUVB) decreased during the last reporting period, falling from 32.10M to 30.81M. This put 12.73% of the company's publicly available shares short.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 16/06/25 | 1.68 | 1.88 | 1.575 | 1.825 | 7,209,068 |
| 13/06/25 | 1.81 | 1.82 | 1.69 | 1.73 | 8,955,051 |
| 12/06/25 | 2.20 | 2.23 | 1.80 | 1.81 | 18,706,289 |
| 11/06/25 | 2.53 | 2.72 | 1.97 | 2.20 | 24,284,539 |
| 10/06/25 | 2.56 | 2.65 | 2.485 | 2.52 | 3,775,141 |
| 09/06/25 | 2.52 | 2.53 | 2.41 | 2.51 | 5,917,576 |
| 06/06/25 | 2.53 | 2.61 | 2.455 | 2.48 | 5,095,094 |
| 05/06/25 | 2.46 | 2.535 | 2.39 | 2.48 | 4,380,565 |
| 04/06/25 | 2.50 | 2.53 | 2.43 | 2.45 | 4,555,086 |
| 03/06/25 | 2.33 | 2.46 | 2.28 | 2.45 | 4,427,863 |
|
|
||||
|
|
||||
|
|